Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Metformin in Alzheimer's Dementia Prevention (MAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04098666
Recruitment Status : Not yet recruiting
First Posted : September 23, 2019
Last Update Posted : November 12, 2019
Sponsor:
Collaborators:
Johns Hopkins University
National Institute on Aging (NIA)
University of Rochester
University of Iowa
Weill Medical College of Cornell University
Boston University
Wake Forest University
Rush University
Pennington Biomedical Research Center
University of Miami
Emory University
Georgetown University
Information provided by (Responsible Party):
José A. Luchsinger, Columbia University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : March 30, 2024
Estimated Study Completion Date : April 30, 2024